Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Sep 02, 16:00
Forte Biosciences Cash and Short Term Investments (Quarterly) : 198.46M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 198.46M |
| March 31, 2026 | 58.22M |
| December 31, 2025 | 76.96M |
| September 30, 2025 | 93.41M |
| June 30, 2025 | 106.14M |
| March 31, 2025 | 45.86M |
| December 31, 2024 | 58.36M |
| September 30, 2024 | 16.36M |
| June 30, 2024 | 24.50M |
| March 31, 2024 | 30.44M |
| December 31, 2023 | 37.12M |
| September 30, 2023 | 46.18M |
| June 30, 2023 | 30.42M |
| March 31, 2023 | 35.90M |
| December 31, 2022 | 41.10M |
| September 30, 2022 | 44.05M |
| June 30, 2022 | 38.55M |
| March 31, 2022 | 40.04M |
| December 31, 2021 | 42.04M |
| September 30, 2021 | 45.66M |
| June 30, 2021 | 50.80M |
| Date | Value |
|---|---|
| March 31, 2021 | 54.76M |
| December 31, 2020 | 58.76M |
| September 30, 2020 | 20.18M |
| June 30, 2020 | 27.75M |
| March 31, 2020 | 14.23M |
| December 31, 2019 | 6.939M |
| September 30, 2019 | 55.34M |
| June 30, 2019 | 68.32M |
| March 31, 2019 | 80.12M |
| December 31, 2018 | 96.09M |
| September 30, 2018 | 79.85M |
| June 30, 2018 | 79.46M |
| March 31, 2018 | 74.00M |
| December 31, 2017 | 88.72M |
| September 30, 2017 | 99.57M |
| June 30, 2017 | 108.64M |
| March 31, 2017 | 28.88M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | 52.56M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| argenx SE | -- |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |
| Savara, Inc. | 173.03M |